Liminal Biosciences Inc (LMNL): Dr. Soon-Shiong pulls trigger to purchas...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	15
Posts	221
Boards Moderated	0
Alias Born	05/09/2014

aframe

Re: None

Tuesday, 02/07/2017 11:38:40 AM

Tuesday, February 07, 2017 11:38:40 AM

Dr. Soon-Shiong pulls trigger to purchase 44,000,000 shares of PFSCF.
Commercializations plasminogen expected in 2017

California Capital Equity, LLC acquires 44 million ProMetic shares through the exercise of all outstanding warrants

PR Newswire PR NewswireFebruary 6, 2017
LAVAL, QC, Feb. 6, 2017 /PRNewswire/ - ProMetic Life Sciences Inc. (PLI.TO) (PFSCF) ("ProMetic" or the "Corporation") announced today that California Capital Equity, LLC, has exercised 44,791,488 share purchase warrants at a price of $0.47 per share for total proceeds of $21,051,999.36 to the Corporation.
"Our increased equity position in ProMetic represents a long term and strategic investment for us", said Dr. Patrick Soon-Shiong, Chief Executive Officer of California Capital Equity, LLC. "ProMetic has robust proprietary therapeutic platforms, promising growth potential and several plasma derived therapeutics expected to reach commercialization stages, starting in 2017 with plasminogen. We, through other investment vehicles, also have an on-going partnership with ProMetic in relation to IVIG and anticipate further collaborations going forward", added Dr. Soon-Shiong.